Richard Tuli, MD, PhD
Richard Tuli, MD, PhD is a radiation oncologist in the Department of Radiation Oncology and member of the Samuel Oschin Cancer Institute.
Dr. Tuli’s primary clinical and research interests are in gastrointestinal oncology. He has a strong interest in the multidisciplinary management of gastrointestinal (GI) cancer patients and is active in further developing this approach at Cedars-Sinai. His clinical research interests include investigating novel radiotherapy techniques, such as image-guidance and stereotactic ablation, to improve clinical outcomes and minimize toxicity.
Dr. Tuli has a strong interest in translational gastrointestinal (GI) research with an emphasis in the management of pancreatic cancer. His primary goal is to accelerate laboratory findings to the clinic through sound preclinical development using a novel small animal radiation research platform for pancreatic and other GI cancers. His current research focuses on the role of PARP inhibition in pancreatic cancer as a mechanism for chemoradiosensitization.
Dr. Tuli has published over 80 research articles, abstracts and book chapters. His research has appeared in peer-reviewed journals, such as the Journal of Biological Chemistry, Annals of Surgical Oncology, Experimental Cell Research, Stem Cells, Translational Oncology and American Journal of Surgery. He is the recipient of several awards, including the ASCO Cancer Foundation Merit Award, AACR Scholar-in-Training Award and The Hyman Menduke Research Prize. Dr. Tuli is a member of several prestigious professional organizations, including the American Society for Radiation Oncology, the American Society of Clinical Oncology and the American Association for Cancer Research. In addition to presenting his research at numerous national conferences, Dr. Tuli also serves as a manuscript reviewer for the International Journal of Radiation, Biology and Physics, Translational Oncology, Journal of Women’s Health and others.
After earning a combined medical and doctorate degree from Jefferson Medical College, Dr. Tuli completed his residency training in radiation oncology at Johns Hopkins Hospital, where he also served as chief resident. Dr. Tuli has also completed a pre-doctoral fellowship at the National Institutes of Health within the National Institute of Arthritis, Musculoskeletal and Skin Diseases.
Click here to learn more about Dr. Richard Tuli.